Leptin R

Leptin R

Leptin R Molekülinformation

Molecule Name
Leptin receptor
Molekülalias
LEPR,CD295,DKFZp686B1731,OBR,Leptin receptor
Drug Development Progress
Anzahl der klinischen Arzneimittel3
Anzahl der inverkehr gebrachten Arzneimittel1
Höchste Forschungs- und EntwicklungsphaseApproved
Target-Alias
CD295,OB receptor,LEPR,HuB219,DB,Leptin Receptor,LEP-R,OB-R,OBR,CD295 Antigen,LEPRD,Receptors, Leptin
Molekülhintergrund
Leptin receptor (LEPR) is also known as LEP-R, cluster of differentiation 295 (CD295), OB-R and B219, is a single-transmembrane-domain receptor of the gp130 family of cytokine receptors. Leptin receptor exists as homodimer and binds Leptin with high affinity, thus mediates the biological function of the adipocyte-specific hormone Leptin. LEPR is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this protein have been associated with obesity and pituitary dysfunction. Interaction of leptin and leptin receptor is crucial for body weight and bone mass regulation in mammals through hypothalamic effects on satiety and energy expenditure. Meanwhile, research data supports a leptin receptor activation model based on ligand-induced conformational changes.

Leptin R Produktliste

Species
  • Human(2)
Tag
  • Fc Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(1)
  • Unconjugated(1)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
Leptin R
Human Leptin R / CD295 Protein, Fc Tag
Human
HEK293
SDS-PAGE

$330.00

100ug
Leptin R
Avitag
LER-H82E3
Biotinylated Human Leptin R Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$368.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
MibavademabREGN-4461Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Amenorrhea; Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Monogenic obesity; Obesity
Details
RG-6436RG6436; RG-6436Phase 1 ClinicalEnterprise Therapeutics Ltd, Genentech Inc
Urinary Tract Infections
Details
ERX-1000ERX-1000Phase 1 ClinicalERX Pharmaceuticals Inc
Obesity
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
MetreleptinKTR-103; AC-164594ApprovedAmylin Pharmaceutical, Astrazeneca Plc, Bristol-Myers Squibb CompanyMetreleptin [SHIONOGI], MyaleptaJapanLipodystrophyShionogi & Co Ltd2013-03-25
Diabetes Mellitus; Diabetes Mellitus, Type 1; HIV Infections; Hyperlipidemias; Insulin Resistance; Lipodystrophy; Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight
Details
Customer Reviews
  • B***™2026-07-22
    This product performed really well in our assay. We observed improved sensitivity when using it as a capture reagent, likely due to its fragment format. The quality and performance were excellent, and I would recommend it for applications requiring sensitive leptin receptor detection.